Phase II Study of Irinotecan/Capecitabine in Patients With Antracycline/Taxane Pretreated MBC
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer Metastatic
Interventions: DRUG: Irinotecan plus capecitabine
Sponsor: National Cancer Center, Korea